Follow-The-Filings

Security · featured owners

CORT Corcept Therapeutics Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 1 exit

CORT (Corcept Therapeutics Inc.) 13F ownership among featured managers we track as of 2026 Q2. Figures are as-filed 13F, not free float.

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
David Witzke - Avidity Partners Management exited 2026 Q2 last 2026 Q1 0.24% Exit −0.24% 30,000 $1M history

0 current · 1 exited last period · options excluded

SEC filings

Recent issuer filings from EDGAR · 4 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 8.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 16 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Sep 14, 2026 Filing Doc
4 Period Sep 1, 2026 · 6 forms Filing Doc
4 Period Aug 26, 2026 Filing Doc
4 Period Aug 25, 2026 Filing Doc
4 Period Aug 18, 2026 Filing Doc
4 Period Aug 17, 2026 Filing Doc
4 Period Aug 14, 2026 · 2 forms Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 10, 2026 · 2 forms Filing Doc
4 Period Aug 4, 2026 Filing Doc
4 Period Aug 3, 2026 · 2 forms Filing Doc
4 Period Jul 30, 2026 Filing Doc
4 Period Jul 15, 2026 · 2 forms Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period May 27, 2026 Filing Doc

Updated about 15 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $482.38M $675.04M $761.41M
Net income $106.14M $141.21M $99.65M
Net margin * 22.0% 20.9% 13.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $458.64M $471.6M $485.46M
Total non-current assets * $162.88M $368.95M $351.19M
Total assets $621.52M $840.55M $836.65M
Total current liabilities $104.5M $140.77M $166.08M
Total non-current liabilities * $10.31M $20.19M $22.76M
Total equity $506.7M $679.59M $647.8M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $127.04M $198.07M $142M
Cash from investing $90.91M -$177.6M $69.76M
Cash from financing -$148.72M -$28.35M -$220.37M
Net change in cash $69.22M -$7.89M -$7.17M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders